Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy
Crossref DOI link: https://doi.org/10.1007/s10198-019-01134-2
Published Online: 2019-11-12
Published Print: 2020-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rodríguez-Sánchez, B. http://orcid.org/0000-0002-6146-068X
Peña-Longobardo, L. M.
Sinclair, A. J.
Text and Data Mining valid from 2019-11-12
Version of Record valid from 2019-11-12
Article History
Received: 18 October 2018
Accepted: 30 October 2019
First Online: 12 November 2019
Compliance with ethical standards
:
: No potential conflicts of interest relevant to this article were reported.